key: cord-0933457-p9iwlw3x
authors: Strumillo, Scheilla T.; Kartavykh, Denis; de Carvalho , Fábio F.; Cruz, Nicolly C.; de Souza Teodoro, Ana C.; Sobhie Diaz, Ricardo; Curcio, Marli F.
title: Host–virus interaction and viral evasion
date: 2021-02-19
journal: Cell Biol Int
DOI: 10.1002/cbin.11565
sha: 5242ca27ed2f9678b05e4ff285519181dcab1731
doc_id: 933457
cord_uid: p9iwlw3x

With each infectious pandemic or outbreak, the medical community feels the need to revisit basic concepts of immunology to understand and overcome the difficult times brought about by these infections. Regarding viruses, they have historically been responsible for many deaths, and such a peculiarity occurs because they are known to be obligate intracellular parasites that depend upon the host's cell machinery for their replication. Successful infection with the production of essential viral components requires constant viral evolution as a strategy to manipulate the cellular environment, including host internal factors, the host's nonspecific and adaptive immune responses to viruses, the metabolic and energetic state of the infected cell, and changes in the intracellular redox environment during the viral infection cycle. Based on this knowledge, it is fundamental to develop new therapeutic strategies for controlling viral dissemination, by means of antiviral therapies, vaccines, or antioxidants, or by targeting the inhibition or activation of cell signaling pathways or metabolic pathways that are altered during infection. The rapid recovery of altered cellular homeostasis during viral infection is still a major challenge. Here, we review the strategies by which viruses evade the host's immune response and potential tools used to develop more specific antiviral therapies to cure, control, or prevent viral diseases.

Recent studies in the immunology field have described some factors that affect the quality and intensity of the host's immune response when it is exposed to infections. Among them, age, gender, genetics, and comorbidities (Fink & Klein, 2015; Hooten & Evans, 2019; Martín et al., 2017; Yao et al., 2018) , perinatal factors, and nutritional status (Alwarawrah et al., 2018; De Medeiros et al., 2018; Obanewa & Newell, 2017; Plaza-Díaz et al., 2018) , environmental factors (Cannon et al., 2019) , socioeconomic status (Meier et al., 2016) , and immunological status may be determining factors for the establishment of a viral infection (Zimmermann & Curtis, 2019 ). The contribution of both viral and host factors determines vulnerability to viral infection and pathogenesis (Zimmermann & Curtis, 2019) . The exact mechanisms of how these factors influence pathogenesis have fundamental importance for the development of infection prevention strategies.

For example, age can be a determining factor in the establishment of a viral infection. In newborns, the immune system is immature. This often represents a deficiency in immune responses, which predisposes these individuals to certain infections with higher pathogenicity. This is what happens when the hepatitis B virus (HBV)

is acquired vertically, in toddlers or even children, being more likely to persist when compared to infection by this virus in adults (Zimmermann & Curtis, 2019) . In addition, the humoral response of newborns is dependent on the vertical transmission of antibodies during pregnancy or breastfeeding (Letson et al., 2004; Victora et al., 2016) .

Poor nutrition leads to global immunodeficiencies in children, adolescents, and the elderly. In 2016, an estimated 159 million children under the age of 5 years worldwide were seen to be wasted or severely wasted and suffered from stunting. In addition, around 45% of deaths among children under the age of 5 years were linked to undernutrition (World Health Organization, 2020) . Moreover, the number of children suffering from malnutrition in West and Central

Africa has increased at an alarming rate from 22.4 million to 29.0 million between 2000 and 2019 (UNICEF, 2020). There is a relationship between undernutrition and infection, with undernutrition compromising immune function or impairing an effective response (Calder & Jackson, 2000) . Poor nutrition leads to a reduced innate immune response following stimulation of important receptors activated by viruses, such as the Toll-like receptor (TLR) superfamily (Djukic et al., 2014; Walker et al., 2011) .

Genetic defects, such as mutations in nucleotide-binding oligomerization domain-like receptors (NLRs) belonging to the pattern recognition receptor (PRR) family (Kim et al., 2016; Kuenzel et al., 2010; Mortaz et al., 2017) , can also contribute towards an ineffective immune response.

The host's first line of defense against a vast array of potentially pathogenic microorganisms, including viruses, is the skin and mucosa, which form part of the innate or nonspecific immune response (Bedeković et al., 2018; Coursaget, 2014) . These anatomical barriers are equally as important as other components of the innate and adaptive immune responses. Local immunity then limits the spread of viruses from the focus of infection and also plays an important role in activation of the adaptive immune response (Carbone & Gebhardt, 2014; Desai et al., 2018) .

Regarding immunological aspects, chemokines play an important role in the regulation of immune cell migration and activation, which is crucial for a comprehensive antiviral immune response (Alkhatib et al., 1996) . Chemokines, such as those regulated on activation, normal T cell-expressed and secreted (RANTES) chemokine, macrophage inflammatory protein 1-alpha (MIP-1α), and MIP 1-beta , are important chemokines that act through C-C chemokine receptor type 5 (CCR5). This receptor is expressed on several immune effector cells such as natural killer (NK) cells, T cells, and macrophages (Alkhatib et al., 1996; Kou & Kuang, 2019) .

During cell activation, viruses enter the cytoplasm and generate double-stranded RNA (dsRNA) during replication. The infected host cells can recognize such dsRNA and activate intrinsic antiviral signaling pathways with the production of interferon (IFN) type I, inducing multiple aspects of innate and adaptive responses (Yoneyama & Fujita, 2008) . This process is mediated by cytosolic PRRs, such as retinoic acid-inducible gene-I (RIG-I), melanoma differentiation-associated protein 5 (MDA5), and laboratory of genetics and physiology protein 2 (LGP2), which are expressed in most cutaneous cell types and in remarkably high levels following exposure to IFN type I (Kawai & Akira, 2009 ).

The C-type lectin receptors (CLRs) expressed in cutaneous antigen-presenting cells (APCs) can also be mentioned in this context. These receptors mediate internalization of the viral ligand or of the virus itself in intracellular compartments, leading to their degradation and subsequent presentation of the antigen to APCs (Mercer & Greber, 2013; Sandgren et al., 2010) . Upon viral activation, these receptors and transcription factors that induce the production of cytokines, such as IFN, interact as mediators of a direct antiviral response regulating multiple aspects of innate and adaptive immune responses.

Besides the above-mentioned mechanisms to decrease viral infection, we also can mention cell-mediated immunity factors related to macrophages, plasmacytoid dendritic cells (pDCs), and NK cells.

Classically activated macrophages (M1-polarized macrophage subtype), when stimulated by IFN-γ or lipopolysaccharides (LPS), induce expression of the enzyme inducible nitric oxide synthase (iNOS or NOS2), which produces nitric oxide (NO) (Karupiah et al., 1993; Kobayashi, 2010; Martinez et al., 2006) . Among the various physiological effects of NO, we can mention its antiviral effects against some viruses, such as Herpes simplex virus type 1 (HSV-1), Japanese encephalitis virus (JEV), and Dengue virus (DENV) (Croen, 1993; Neves-Souza et al., 2005; Saxena et al., 2000) , among others. Concurrently, alternatively activated macrophages (M2-polarized macrophage subtype) are stimulated by cytokines and are found in high levels in human infections caused by the hepatitis C virus (HCV) and hepatitis B virus (HBV) (Saha et al., 2016; Tsai et al., 2018) .

The importance of pDCs in the context of the innate immune response is that these cells express the TLR7 and TLR9 intracellular receptors, which recognize viral or microbial nucleic acids (Asselin-Paturel & Trinchieri, 2005; Y. Liu, 2005) . This happens when pDCs secrete IFN type I, following activation of TLRs triggered by viruses or immune complexes (Cella et al., 1999) .

Despite the restrictive factors mentioned above, almost all viral pathogens have developed mechanisms to inhibit the activation of complement system proteins (Lambris et al., 2008) by the production of molecules that bind to the Fc region of host immunoglobulins to prevent immunoglobulin G (IgG)-mediated virus neutralization (Lilley et al., 2001; Sprague et al., 2008) and the induction of antibody-dependent activities against infected cells. The binding of antibodies to epitopes on the surface of infected cells results in activation of the complement pathway and cell lysis (Martinez et al., 2006; Van de Walle et al., 2003) . Inhibition of its activation or binding to viruses ensures the development of a viral infection, as we will see in more detail throughout this review.

Within the context of the cellular immune response, the cyto- (Grinde, 2013) .

In addition to the inactivation of MHC class I and/or MHC class II receptors, the persistent activation of T cells induces an inflammatory condition (Belkaid & Rouse, 2005) that can lead to tissue or systemic damage. Influenza virus infection may induce lung inflammation with massive tissue damage (Julkunen et al., 2000) . (Inoue et al., 2003; Jones et al., 2011; Speck et al., 2000; Wilen et al., 2012) . In addition to inhibiting apoptosis by means of the production of caspase inhibitors, viruses can hide viral proteinto-peptide processing that occurs in proteasomes present in the cytosol. For example, the Epstein-Barr nuclear antigen 1 (EBNA1) escapes CTL detection and encodes a mechanism to inhibit epitope generation (Levitskaya et al., 1997) .

Some mechanisms have been suggested to explain the viral evasion of novel SARS-CoV-2, which involves CpG deficiency, 2'-Omethylation of viral RNA, viral suppressor RNAi, and the ORF8 and ORF3b proteins, which will be discussed further in this review.

Further to the various viral immune evasion mechanisms described above, understanding how viruses are capable of sequestering host cell metabolism, by inducing increased absorption and catabolism of nutrients in the host cell to support the production of new progeny, is an interesting challenge that could reveal how these evasion strategies or modulation of the host metabolism translate into the clinical outcome of the infection, or how current therapies could prevent the persistence of viral infection.

The contribution of viral and host factors determines vulnerability to viral infection and pathogenesis. The exact mechanism of how these factors influence pathogenesis is of fundamental importance for the development of strategies to prevent infection.

There are some factors that affect the quality and intensity of the host's immune response when it is exposed to viral infections, as described below. 

Age can be a determining factor in establishing a viral infection. In newborns, the immune system is not fully developed. The humoral response of newborns and toddlers relies on the passive transfer of maternal antibodies during pregnancy or breastfeeding. These antibodies influence the vaccination process as they act as neutralizers of the vaccine agent. Children are therefore vaccinated after 6 months of age, long enough to avoid interference of maternal antibodies (Jakaitis & Denning, 2014) .

A lot of changes in innate and adaptive immunity are common in the aging population, reflecting a deterioration of the immune system and leading to terms such as "immune aging" or "im- Decreased immunological functions lead to increased susceptibility of the elderly to viral, bacterial, and fungal infections, reactivation of pre-existing latent viruses, and a reduced response to vaccines (Franceschi et al., 2000; O'Connor et al., 2014) .

In addition, metabolic dysfunction, impaired immune response to new antigens and inflammatory disorders are commonly found in the elderly and reflect a strong link between metabolic dysregulation and immune responses. Another example of this strong link is that several metabolic syndromes, especially obesity and diabetes, have inflammatory components (e.g., interleukin-6 and advanced glycation end products [AGEs] that trigger oxidative stress) and appear to be a driving force behind the pathogenicity of many viral infections (Franceschi et al., 2000; O'Connor et al., 2014) .

Chemokines such as RANTES, MIP-1α, and MIP-1β are important chemokines that act through CCR5 (Sanchooli et al., 2014) , which is a member of the heterotrimeric G protein superfamily, and its activation results in the recruitment of proteins from cell signaling pathways, more specifically: Rho GTPase, PI3-Kinase, MAPK, JAK/ STAT, and PKB (Sorce et al., 2011; Wong et al., 2001) . The activation of these signaling pathways is implicated in the proliferation of immunological cells, the expression of inflammatory cytokines, activation of the immune system, and a protective response to viral infections such as Influenza, CMV, HSV-1, HSV-2, HBV, and HCV (Piguet & Trono, 2001) . In contrast to the viruses mentioned above, for HIV, CCR5 is a coreceptor that facilitates entry into CD4+ T cells. The interactions between viral phenotypes, tropism, and the use of coreceptors, and how these influence HIV pathogeneses are important topics in HIV research, especially after two cases of HIV being cured following a bone marrow transplant from a homozygous CCR5 Δ32 donor (Brown, 2015; Gupta et al., 2020; Hütter et al., 2009; Symons et al., 2014) .

Some micronutrients have a direct relationship with the formation of antibodies and development of the immune system:

• Vitamin A supplementation maintains intestinal integrity, reduces the incidence of respiratory tract infections, mortality from diarrhea, and increases immunity. Measles depletes host vitamin A levels, and for this reason, the measles vaccination often includes a high dose of vitamin A (Oliveira & Rondo, 2007) . • Zinc deficiency is implicated in reduced neutrophil and NK cell immunity, reduced complement system activity, a decrease in T and B cells, suppression of late hypersensitivity and cytotoxic activity, and also reduced antibody production (Sena & Pedrosa, 2005) .

• Breastfeeding: Immune deficiency is partially offset by breastfeeding. Breast milk has large amounts of IgA, secreted lysozyme from macrophages, T and B cells that release IFN-g, migration inhibitory factors, and monocyte chemotactic factors. Thus, breast milk actively boosts the immune system through the transfer of antibodies and lymphocytes (Palmeira & Carneiro-Sampaio, 2016) . 

TLRs are the best characterized among those that integrate the family of PRRs and participate in the recognition of viral components.

TLRs contain extracellular leucine-rich repeats that mediate the recognition of their respective pathogen-associated molecular patterns (PAMPs).

Nucleic acids of RNA and DNA viruses, such dsRNA, singlestranded RNA (ssRNA), and demethylated CpG rich motifs (CpGDNA), are considered to be PAMPs and can be recognized by TLRs 3, 7, 8, and 9, which are located in intracellular compartments, such as endosomes and the endoplasmic reticulum (Gantier, 2014) .

TLR3 recognizes dsRNA, TLR7 and TLR8 recognize ssRNA, and TLR9 recognizes demethylated CpG rich motifs. TLRs 1, 2, 4, 5, and 6 are located on the cell surface and primarily recognize components of the bacterial cell wall and viral particles. The specialty of TLRs is to promote the production of IFN type I and inflammatory cytokines, leading to antiviral immunity ( Figure 1 ) (Collins & Mossman, 2014) .

TLR2 can be stimulated by various skin-associated viruses, including HSV, VZV, EBV, human and murine cytomegalovirus (HCMV and MCMV), and measles virus. In many of these cases, viral stimulation of TLR2 results in activation of the AP-1 transcription factor, which contributes to the induction of proinflammatory cytokine expression (Boo & Yang, 2010) .

Activation of TLR3 in Epstein-Barr infection contributes to the release of inflammatory cytokines and viral RNA from infected cells.

Subsequently, the production of IFN type I and tumor necrosis factor α (TNF-α) occurs. 

| 5 mediated by IFN-α (Bonvin et al., 2006) . The antiviral effect of APOBEC3G has been explored in a broad range of retroviruses, including HIV-1, where the induction of G-to-A hypermutation in the nascent retroviral DNA of viral infectivity factor (Vif)-defective HIV-1 has been observed (Mangeat et al., 2003; H. Zhang et al., 2003) . APOBEC3G can also bind to a retroviral RNA template or ssDNA and inhibit the viral reverse transcriptase (RT), leading to the production of nonviable viruses (Chemudupati et al., 2019) .

Nucleotide 

Macrophages can adopt a variety of active phenotypes, depending on the cellular environment in which they are found. Classically activated macrophages (M1-polarized macrophage subtype), when stimulated by IFN-γ or LPS, induce expression of the enzyme inducible nitric oxide synthase (iNOS or NOS2), which produces NO ( Figure 2a ) (Buzzo et al., 2017) . Evidence shows that DC glycolytic upregulation is controlled by two distinct pathways; an early burst of glycolysis that is NO-independent, and a sustained commitment to glycolysis in NO-producing DC subsets (Thwe & Amiel, 2017) . NO is a short-lived gas molecule that causes both physiological and pa- Only influenza A and B cause outbreaks of pandemics and severe disease (Couch & Kasel, 1983) . These viruses have two surface antigenic proteins; hemagglutinin (HA or H) and neuraminidase (NA or N), with 16 subtypes of HA and 9 of NA having been described (Fouchier et al., 2005) . 

Among the cellular immune responses, we can highlight those mediated by CD4+ and CD8+ T cells. can also act directly on increasing the proliferation of CD8+ T cells.

Other cytokines produced by innate immunity cells reinforce signaling mediated by IFN type I to ensure the expansion and function of cytotoxic CD8+ T cells (Mescher et al., 2006) . IL-12 produced by macrophages and dendritic cells induces the expression of T-bet transcription factor (T-box expressed on T cells) (Joshi et al., 2007) . induces lung inflammation with massive tissue damage (Lê et al., 2015) . (Vasileiou et al., 2020) . In addition to the production of proinflammatory cytokines by activated T cells, we can cite "original antigenic sin" or "negative antigenic interaction" (Monto et al., 2017) , which is defined by the tendency of the immune system to utilize immune memory based on the first infection, when a second, slightly different infection attempts to establish itself. Original antigenic sin is particularly harmful in influenza virus infections, dengue, and vaccinations. In the case of dengue, CD4+ and CD8+ T cell activation will be more potent in the secondary infection, resulting in a worse clinical condition compared to the traditional fever. This is because of the release of the cytokines IFN-γ and TNF-α, which can act directly in endothelial cells, promoting vascular injury and contributing towards plasma extravasation and the pathogenesis of hemorrhagic dengue (Dalrymple & Mackow, 2014) . In the case of vaccinations, viruses can undergo antigenic variation, where their epitopes are altered through natural mutations, allowing them to escape the immune system. When this occurs, the mutated virus reactivates previously activated memory B cells, which produce antibodies. However, these antibodies associate inefficiently with the altered epitopes. There will therefore be no activation of naive B cells capable of creating new antibodies against this viral strain. The consequence is a less efficient immune response than the previous ones and with a longer course of infection (Dalrymple & Mackow, 2014) .

The coexistence of viruses and hosts imposes evolutionary pressure on the immune system. The host has developed an immune system that can respond to viruses and cells infected by them (H.K. Lee & Iwasaki, 2008; Seth et al., 2006) . On the other hand, viruses have developed several immune evasion mechanisms to escape the host's immune system (Alcami & Koszinowski, 2000) . Generally, the larger the viral genome, the more diverse the mechanisms used to extend the time of viral replication and the spread of viral particles.

Various mechanisms of evasion enable viruses to avoid recognition by the host's humoral immune response (Alcami & Koszinowski, 2000; Medzhitov, 2007) . These mechanisms include altering immunodominant epitopes; interfering with the cellular immune response, for example, by disabling peptide presentation or affecting the performance of NK cells; and interfering with immune effector functions, for example, by affecting the expression of cytokines or blocking apoptosis, which are discussed below.

In Section 4.2.2 we briefly described the role of CD8+ T cells in chronic viral infections and the influence these cells have on viral latency. As mentioned, the reversible state of a nonproductive viral infection in host cells is called latency. Viruses can elude the host's immune responses, becoming latent and invisible to the immune system (Wiertz et al., 1997) . During latency, viruses can infect nonpermissive or semipermissive host cells and persist in "immune privileged" tissues, such as the brain, retina, and kidney. This occurs with HSV-1, which infects and replicates in epithelial cells but can also persist in the form of latent infection, with low viral gene expression in sensory neurons of triplet ganglia that do not express MHC antigens (Garber et al., 1997; T. Liu et al., 2000) . After certain stimuli, such as immunosuppression, trauma, exposure to sunlight or ultraviolet radiation, the virus can be activated and migrate through the axons of the neurons and infect epithelial cells. In the same way, VZV becomes latent in the dorsal root ganglia of the spinal cord (Gilden et al., 2011) . CMV persists for a long time in the kidneys (Holma et al., 2000) , retina (Voigt et al., 2018) , and bone marrow (Bhat et al., 2015) . HIV-1 is known to persist in the form of the transcriptionally inactive provirus in the CD4+ T cell genome of the host's memory cells for long periods (Gilden et al., 2011; Lungu et al., 1995) . These cells lack the necessary transcription factors for the virus to replicate. Thus, the virus can remain in the brain, where it is protected by the blood-brain barrier against lymphocyte infiltration.

These cells and tissues serve as reservoirs for viruses, which are resistant to therapy and pose a real challenge for complete elimination in the infected host.

Virus-infected cells are normally recognized and eliminated by the immune system. One of the key steps to this is the presentation of viral peptides to MHC class I proteins, allowing the infected cells to be detected and killed by CTLs. In the case of HIV, this process works well, but only temporarily. A strong CTL response can be detected early after infection with a 1%-5% increase in the number of CD8+ T cells (Perreau et al., 2013) , and is responsible for the abrupt decrease (Senkevich et al., 1996) . All γ-herpesvirus encoding

FLIPs also encode a Bcl-2 homolog, which provides two complementary antiapoptotic functions (Hu & Usherwood, 2014) . Thus,

FLIPs facilitate viral propagation and persistence and contribute to the transforming capabilities of some herpes viruses. In addition to the production of FLIPs, viruses can also interfere in cell death signaling at a receptor level (Irmler et al., 1997; Nagata, 1997) . As an example, we can mention the Adenoviral E3-10.4/14.5 K protein that triggers the internalization of Fas (cell death receptor) present on the surface of infected cells and its destruction in lysosomes (Irmler et al., 1997) . As another example of the induction of apoptosis, we can mention IL-24, which is associated with apoptosis in tumor cells (Shisler et al., 1997) and infections caused by Influenza A (Seong et al., 2016; Weiss et al., 2015) and HIV-1 .

mechanism, blocking the spread of viral progeny. Another retrovirus, HTLV-1, also has a tropism for T cells. The HTLV-1 Tax protein is responsible for cell transformation as a result of its interaction with cellular transcription factors, such as NF-κB, resulting in its permanent activation, providing growth of lymphocytes independently of IL-2 (Tagaya et al., 2019) .

In addition to HTLV-1, EBV and HHV-8 (herpesviruses associated with Kaposi's sarcoma) also present sites of association with NF-κB and its promoters (Keller et al., 2006) , resulting in sustained activation and inducing cell transformation. EBV has a tropism for epithelial cells and B cells (Borza & Hutt-Fletcher, 2002) , and is capable of inducing tumors and lymphomas. The EBV LMP-1 protein mimics the activated CD40 receptor (Gires et al., 1997; Kilger et al., 1998) , which promotes the survival, proliferation, and expression of infected B cells. (2) gp120 epitope mutation;

(3) Bcl homologue production; (4) gp120 association with CXCR4 or CCR5; (5) ILs binding ILR; (6) Inhibition of proteasomal degradation; (7) TAP-mediated transport blockade (8,9) Inhibition of presentation by MHC class I and its analogues; (10) Inhibition of apoptosis by Bcl homologues. Bcl-2, B-cell lymphoma 2; CCR5, C-C chemokine receptor type 5; CXCR4, C-X-C chemokine receptor type 4; ILR, interleukin receptor STRUMILLO ET AL.

| 11 and the term virokine was coined (Kotwal & Moss, 1988) for such immunomodulatory molecules as viral homologs of cytokines. Another term coined was viroceptors for viral homologs of cytokine receptors, produced and secreted by virus-infected cells. Since then, many research studies have been dedicated to exploring their potential use as therapeutic agents showing the potential implications for viral epidemiology, treatment or prevention of viral and inflammatory diseases, and for the development of safer vaccines (Kontsek & Kontsekova, 2000) . Many of these proteins are being investigated for use as novel therapeutic immunomodulators to manage immune disorders, inflammation after trauma, graft rejection, and autoimmune diseases (S. A. Smith & Kotwal, 2001) . Also, these viral elements, which induce or subvert the host's cytokine through the transporter associated with antigen processing (TAP). The peptides carried by TAP are anchored to MHC class I (Hengel et al., 1997) . Viruses can escape the processing of these proteins into peptides by altering parts of their genome, via viral proteins. EBV encodes the Epstein-Barr nuclear antigen 1 (EBNA1), escaping detection by CTLs, and encodes a mechanism to inhibit epitope generation (Levitskaya et al., 1995) . HMCV expresses the US6 protein in the initial phase of infection, which inhibits TAP, and its presence in the late phase of viral replication limits the presentation of structural viral antigens such as glycoprotein B. HSV 1 and 2 encode the cytoplasmic protein ICP47, which obstructs the peptide binding site in TAP, thereby blocking the presentation of viral peptides to MHC class I (Ahn et al., 1996; Androlewicz et al., 1993; Iannello et al., 2006) . (Rölle et al., 2018) .

Moreover, the expression of some viral sequence variations can also lead to engagement of KIRs for resistance of viruses to NK cells.

At least one HLA-presented immunodominant epitope derived from HIV p24 protein associated with HLA-E has been identified that allows engagement of KIRs to inhibit NK cell function (Fadda et al., 2012) by increasing the expression of this antigen on the surface of virus-infected cells (Sharpe et al., 2019) . The epitopes derived from HCMV glycoprotein UL40, presented to NK cells by HLA-E molecules via CD94/NKG2A receptor also protect infected cells from NK cell-mediated killing (Heatley et al., 2013) .

The presence of HLA class I antigens on the surface of infected cells and the natural selection of viral epitope variations provide novel opportunities for viral escape from immune response through engagement of KIRs (Heatley et al., 2013; Hölzemer et al., 2015) .

However, this viral evasion strategy needs to be investigated in more detail.

Viral interference with the complement system can be analyzed at several levels. First, some viruses can express viral proteins that mimic the cellular function of the cellular RCA (described in Section 2.4).

HSV-1 encodes a C-glycoprotein which induces the dissociation of the altering C3 convertase pathway (Fries et al., 1986) . Second, some enveloped viruses such as the Newcastle disease virus (Biswas et al., 2012) and vaccinia virus are able to incorporate host RCA (Vanderplasschen et al., 1998) into its envelope by budding through the plasma membrane or intracellular vacuoles. Third, some viruses secrete a complement control protein (VCP) that shares similar amino acids with mammalian RCA and is able to interact with the proteins of the C3 convertase pathway (Agrawal et al., 2017) .

Infected cells can also be lysed by complement-dependent antibodies. The binding of antibodies to epitopes on the surface of infected cells results in inactivation of the complement pathway and lysis of the cells. Some viruses produce molecules that bind to the Fc region of host immunoglobulins. Such virally encoded receptors

(v-FcRs) may prevent IgGs from neutralizing free viruses (Daeron & Nimmerjahn, 2014; Lilley et al., 2001) and engaging antibodydependent activity against the infected cells.

Recently, metabolomics has allowed a deeper understanding of host cell metabolic disorders induced by infectious diseases, which result from the infectious agent using the host cell's metabolism to their advantage for replication and persistence. Early studies have demonstrated the upregulation of glycolytic machinery during viral infection, which was seen from the replication of poliovirus in HeLa cells. Replication was blocked using a culture medium composed of solely a balanced saline solution, and next the proliferation and viral load were restored to their normal levels by restoring glucose supplementation (Darnell & Eagle, 1958) . Subsequent studies have confirmed these findings, highlighting the molecular mechanism associated with glucose metabolism and the impact on the progression of HIV infection. After activation of T cells, a dramatic metabolic reconfiguration process occurs, which stimulates lymphocyte signaling to the detriment of the high bioenergetic demand influencing differentiation, growth, proliferation, and development of their effector functions (Buck et al., 2015) .

It has been demonstrated that TCR activation and the costimulation of CD28 are required to allow maximal uptake of glucose by promoting upregulation and trafficking of glucose-cell transporter 1 (GLUT1) from the cell surface of T cells (Jacobs et al., 2008) . In metabolically quiescent T cells, reverse transcription is blocked, as well as the integration of full-length HIV-1 DNA. Thus, the HIV genome remains mainly in the linear and nonintegrated form, mitigating viral replication (Bukrinsky et al., 1991; Chun et al., 1997) .

GLUT1 expression and glucose uptake appear to be essential for adequate CD4+ T-cell infection (Loisel-Meyer et al., 2012; Palmer et al., 2014) . In the same way, Th17 responses are characterized by the expression of the C-C chemokine receptor 6 (CCR6) and hypoxiainduced factor 1 alpha (HIF-1α), a central regulator of glucose metabolism (Shi et al., 2011) .

It has been suggested that polarization towards the Th1/Th17 phenotype promotes HIV persistence during highly active antiretroviral therapy (HAART), with Th17 being an important reservoir for HIV (Gosselin et al., 2017; Stieh et al., 2016) . In accordance with this, evidence has shown that HIV-infected individuals treated with ART have decreased numbers of circulating CD4+ T cells expressing GLUT1 (Palmer et al., 2014) , and this expression could be used as a measure of persistent immune activation associated with viral persistence.

Several other viruses also hijack the glycolytic machinery to their own advantage. KSHV induces aerobic glycolysis and lactic acid production, which decreases mitochondrial oxidative phosphorylation to maintain the latent state of the virus (Delgado et al., 2010) .

Hyperglycemic nude mice treated with telomerase-immortalized human umbilical vein endothelial KSHV-infected cells (TIVE-KSHV) have been shown to express higher levels of HSHV lytic genes (Ye et al., 2016) . THP-1 cells infected by KSHV have shown hyperactivation of AKT and translocation of GLUT-1 to the plasma membrane of infected cells (Gonnella et al., 2013) . Nontumorigenic breast epithelial cell line MCF10A infected by adenovirus activated MYC, a proto-oncogene, which increased glucose metabolism (Thai et al., 2014) . DENV-infected cells have shown various glycolytic metabolites that are over-regulated in the early postinfection stage and downregulated in later stages (Fontaine et al., 2015) .

Owing to interest in the recent outbreaks of fetal microcephaly induced by Zika virus infection, it was proposed that Zika modulates GLUT1 function by preventing normal glucose flow in placental endothelial cells, impacting normal fetal growth (Blonz, 2016) . As with other viruses of the Flavivirus family, the Zika infection is similar to DENV. They use glucose uptake to increase bioenergetic demand and cellular biomass. Therefore, it is not surprising that viral modulation of glucose metabolism in the host cell is required for optimal virus replication (Jordan & Randall, 2016) .

A perfect mechanism of viral evasion is confirmed by the virusinduced changes in host glycolytic machinery, which are essential for the development of a successful infection and are likely to contribute to the pathogenesis observed in distinct infections. Nevertheless, the precise molecular mechanisms that drive this reprogramming continue to be researched. In the future, pharmacological drugs that specifically target lymphocytes and the glycolytic pathway could be combined with antiviral therapies to achieve a better clinical outcome.

Cell signaling pathways are activated or inhibited by modulation of the redox environment, resulting in the production of reactive oxygen and/or nitrogen species as the initial trigger during a viral infection. The virus-promoted redox changes can induce conformational changes in key host proteins, contributing to the success of their viral replication.

HIV infections are typically accompanied by chronic microinflammation and T-cell activation with high levels of inflammatory cytokine secretion, and high levels of intracellular generation of ROS (Emilie et al., 1994; Israël & Gougerot-Pocidalo, 1997 antioxidants to reduce ROS levels in HIV-infected patients has been extensively examined (Allard et al., 1998; R. Lee et al., 1997; Mandas et al., 2009; Martin et al., 2001) .

The imbalance between ROS production and elimination during HIV-1 infection is well established (Kruman et al., 1998; Yang et al., 2009 ). Several groups have demonstrated these events either by measuring H 2 O 2 production and the viral load or by comparing the regulation of transcription factors (e.g., NF-κB) during the interplay between ROS production and HIV-1 replication (Mihm et al., 1991; Nabel & Baltimore, 1987) . These results suggest that distinct pathways regulate ROS turnover with a direct impact on HIV-1 replication (Kruman et al., 1998; Schreck et al., 1991; Westendorp et al., 1995) . In addition, the signaling free radical NO also plays an important, albeit dual role in HIV-1 infection. NO may be beneficial to the host through inhibition of viral enzymes or damaging (harmful) through activation of cellular signaling proteins that will support virus replication (Bogdan, 2001; Krogh et al., 2014; Mannick, 1995; Mannick et al., 1999) .

As the protective and toxic effects of NO production often coexist, different NO concentrations should also be correlated with pathological and cytotoxic states (Beckman & Koppenol, 1996) . The pathogenic effects of NO-mediated events depend upon the formation of secondary intermediates, such as peroxynitrite anion (ONOO − ) and nitrogen dioxide (NO 2 ), which are more reactive than NO itself (Brito et al., 1999; Radi et al., 2001) . The interplay between ROS and NO is involved in normal and pathological conditions primarily through the nitration of tyrosine residues on target proteins (Bogdan, 2001) . (Cairoli et al., 2008) .

The cellular redox state in lymphocytes may be modulated by endogenous generation of ROS and NO. These reactive species can interfere with the biochemical parameters of cell activation (Lander, 1996; Lander et al., 1996) . Furthermore, exogenously supplied oxidants such as haemin and the NO donors sodium nitroprusside (SNP) and S-nitroso-N-acetylpenicillamine (SNAP), stimulate tyrosine phosphorylation and regulate signaling pathways in fibroblasts, endothelial cells and lymphocytes (Curcio et al., 2010; . However, the redox regulation of signaling pathways triggered by HIV infection is poorly understood. 6 | MECHANISMS OF SARS-COV-2 EVASION 6.1 | CpG deficiency CpG deficiency is a common feature of ssRNA viruses, including coronaviruses Greenbaum et al., 2008 Greenbaum et al., , 2009 Takata et al., 2017; Yap et al., 2003) . The zinc-finger antiviral protein (ZAP) binds specifically to CpG dinucleotides in viral RNA genomes and is responsible for IFN-mediated immune response (Meagher et al., 2019) .

SARS-CoV-2 has the lowest index CpG (ICpG) when compared to their viral genome relatives (Xia, 2020) . It has been suggested there is an association between decreased CpG and increased virulence in many Züst et al., 2011) . SARS-CoV-2 is a unique virus that requires interaction between the nsp10 and nsp16 proteins for nsp16 to execute its 2'O-MTase activity (Chen et al., 2011; Decroly et al., 2011; Encinar & Menendez, 2020; Lugari et al., 2010) .

The nucleocapsid protein (N protein) of SARS-CoV-2-infected human cells has shown suppression of antiviral RNAi activity (Mu et al., 2020) . A previous study of N protein on SARS-CoV demonstrated a resembling effect, suggesting that N proteins function as a VSR (Cui et al., 2015) . Similar VSR activity in coronavirus genome relatives 14 | C Cell ell B Biology iology I International nternational might be explained by the high homology (94%) among coronavirus N proteins (Mu et al., 2020) .

A phylogenetic analysis of the accessory protein orf8 from SARS-CoV and SARS-CoV-2 revealed that this new coronavirus has an orf8 distant from the conserved one derived from human SARS-CoV. This novel orf8 probably impairs the activation of intracellular stress pathways and of NLRP3 inflammasomes, due to the absence of an aggregation motif (VLVVL-amino acids 75-79) that is found on SARS-CoV orf8b that might initiate said activation (Chan et al., 2020) . Orf8 might also down-regulate MHC class I molecules on the surface of various cell types, disrupting antigen presentation and reducing the recognition and elimination of virus-infected cells by

CTLs (Park, 2020; .

The SARS-CoV-2 orf3b protein presents only 32% amino acid identity homology to SARS-CoV, indicating the codification of a novel orf3b short protein (Chan et al., 2020) . A previous study has found that orf3b is capable of inhibiting the expression of IFN-β at synthesis and signaling levels (Kopecky-Bromberg et al., 2007) . A recent study has shown that the orf3b of SARS-CoV-2 and SARS-CoV not only differ in their length but also in their ability to antagonize IFN type I (Konno et al., 2020) . Surprisingly, ORF3b is highly detectable during the early phase of SARS-CoV-2 infection (Hachim et al., 2020) and impaired IFN type I responses as well as reduced IFN-stimulated gene expression are associated with severe COVID-19 disease in patients (Hadjadj et al., 2020) .

Viruses can use the host's machinery and develop mechanisms to mislead the immune system to ensure their replication and spread through organisms. This review discusses some of these mechanisms and highlights the importance of understanding them to support the development of novel pharmacological strategies to treat viral infections.

We thank Dr. Yvette May Coulson Thomas Norton for support with the technical manuscript review. This study was supported by the CNPQ (Grant 441817/2018-1) .

Data sharing not applicable, no new data generated. Data sharing is not applicable to this article as no new data were created or analyzed in this study. 

CD8+ T cell responses to lytic EBV infection: Late antigen specificities as subdominant components of the total response

Complement evasion strategies of viruses: An overview

Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47

Nitric oxide and virus infection

Viral mechanisms of immune evasion

CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1

Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects

The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1

Changes in nutritional status impact immune cell metabolism and function

Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner

Increasing the CpG dinucleotide abundance in the HIV-1 genomic RNA inhibits viral replication

Production of type I interferons: Plasmacytoid dendritic cells and beyond

The influence of CpG and UpA dinucleotide frequencies on RNA virus replication and characterization of the innate cellular pathways underlying virus attenuation and enhanced replication

Role of human macrophage polarization in inflammation during infectious diseases

How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth

Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly

Detection of lumpy skin disease virus in skin lesions, blood, nasal swabs and milk following preventive vaccination

Natural regulatory T cells in infectious disease

C-Type lectin receptors in antiviral immunity and viral escape

Cytomegalovirus infection in the bone marrow transplant patient

Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion

Zika virus and GLUT1. The Lancet Infectious Diseases

Nitric oxide and the immune response

Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication

Intrinsic cellular defenses against virus infection by antiviral type I interferon

Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus

In vitro reconstitution of SARS-coronavirus mRNA cap methylation

Single-cell analysis of quiescent HIV infection reveals host transcriptional profiles that regulate proviral latency

Editorial: Switching on arginase in M2 macrophages

Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death

I am the berlin patient: A personal reflection

Activation of RIG-I-like receptor signal transduction

T cell metabolism drives immunity

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons

The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases

Predicting the evolution of human influenza A

Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage

HIV-1 induced decrease of nitric oxide production and inducible nitric oxide synthase expression during in vivo and in vitro infection

Undernutrition, infection and immune function

Environmental and social determinants of acute rheumatic fever: a longitudinal cohort study

CTLA-4 interferes with the HBVspecific T cell immune response (Review)

A neighborhood watch upholds local immune protection

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Nitric oxide in dengue and dengue haemorrhagic fever: Necessity or nuisance?

From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections. Biochimica et biophysica acta

Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase

Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex

Regulation of RIG-I-like receptor signaling by host and viral proteins

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells

Danger, diversity and priming in innate antiviral immunity

Structure and diversity of influenza virus neuraminidase

Immunity to influenza in man

Viruses associated with skin and mucosal cancers

Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication

The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells

Nitric oxide stimulates a PKC-Src-Akt signaling axis which increases human immunodeficiency virus type 1 replication in human T lymphocytes

Regulatory effects of nitric oxide on Src kinase, FAK, p130Cas, and receptor protein tyrosine phosphatase alpha (PTP-alpha): a role for the cellular redox environment

Fc receptors

2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members

Virus interactions with endothelial cell receptors: Implications for viral pathogenesis

Glucose and glutamine in poliovirus production by HeLa cells

Modulation of intestinal immune and barrier functions by vitamin a: implications for current understanding of malnutrition and enteric infections in children

Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-Omethyltransferase nsp10/nsp16 complex

Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells

Infectivity and growth kinetics of Herpes Simplex Virus type-2 in MOLT4 CCR5+ and CEM CCR5+ T cell lines

Vitamin D deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells

Role of toll-like receptors (TLRs) and nucleotide-binding oligomerization domain receptors (NLRs) in viral infections

Innate and adaptive immune responses in chronic HCV infection

Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients

Cytokines in HIV infection

Potential drugs targeting early innate immune evasion of SARS-coronavirus 2 via 2'-O-methylation of viral RNA

HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function

Sex and gender impact immune responses to vaccines among the elderly

Human natural interferon-alpha producing cells

Dengue virus induces and requires glycolysis for optimal replication

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls

Inflamm-aging: An evolutionary perspective on immunosenescence

Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans

Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade

CpG and UpA dinucleotides in both coding and non-coding regions of echovirus 7 inhibit replication initiation postentry. eLife, 6, e29112

Processing of double-stranded RNA in mammalian cells: A direct antiviral role

A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1

NK cells in autoimmune diseases: Linking innate and adaptive immune responses

Review: The neurobiology of varicella zoster virus infection

High-dose of vitamin D supplement is associated with reduced susceptibility of monocyte-derived macrophages to dengue virus infection and proinflammatory cytokine production: An exploratory study

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule

Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: Report from the Women's Health Study

Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line

HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths

Patterns of evolution and host gene mimicry in influenza and other RNA viruses

Patterns of oligonucleotide sequences in viral and host cell RNA identify mediators of the host innate immune system

Herpesviruses: Latency and reactivation-Viral strategies and host response

High-dose antioxidant supplements and cognitive function in community-dwelling elderly women

Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report

ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells

A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter

Expression of the cytomegalovirus genome in kidney allografts during active and latent infection

Age and poverty status alter the coding and noncoding transcriptome

Immune escape of γ-herpesviruses from adaptive immunity

Selection of an HLA-C*03:04-restricted HIV-1 p24 gag sequence variant is associated with viral escape from KIR2DL3+ natural killer cells: Data from an observational cohort in South Africa

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

Viral strategies for evading antiviral cellular immune responses of the host

Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids

Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

Inhibition of death receptor signals by cellular FLIP

Oxidative stress in human immunodeficiency virus infection

Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways

Human breast milk and the gastrointestinal innate immune system

Vitamin D in human immunodeficiency virus infection: influence on immunity and disease

Molecular aspects of HTLV-1 entry: Functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors

Flavivirus modulation of cellular metabolism

Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor

Inflammatory responses in influenza A virus infection

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

Toll-like receptor and RIG-I-like receptor signaling

The roles of TLRs, RLRs and NLRs in pathogen recognition

Viral Infection

Innate and intrinsic antiviral immunity in skin

NF-kappaB is essential for the progression of KSHV-and EBV-infected lymphomas in vivo

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

NOD-like receptors in infection, immunity, and diseases

Virokines in the pathogenesis of cancer: Focus on human herpesvirus 8

The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation

SARS-CoV-2 ORF3b Is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant

Virokíny a viroceptoryimunomodulátory vírusov s klinickým a terapeutickým dosahom [Virokines and viroceptors-viral immunomodulators with clinical and therapeutic implications

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins

Chapter 6-Mutations in chemokine receptors and AIDS

HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways

HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress

The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses

Regulation of antiviral CD8 T-cell responses

DCIRmediated enhancement of HIV-1 infection requires the ITIMassociated signal transduction pathway

Complement evasion by human pathogens

Cellular activation mediated by nitric oxide

Haemin enhancement of glucose transport in human lymphocytes: Stimulation of protein tyrosine phosphatase and activation of p56lck tyrosine kinase

Redox regulation of cell signalling

Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds

Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis

Autophagy and antiviral immunity

Selective inhibition of IκBα phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds

Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1

Induction and function of type I and III interferon in response to viral infection

Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fcbinding protein

CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

Glut1-mediated glucose transport regulates HIV infection

Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: Signaling cross talk

Molecular mapping of the RNA Cap 2'-Omethyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16

NK cell subset redistribution during the course of viral infections

Reactivated and latent varicella-zoster virus in human dorsal root ganglia

Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

The antiviral role of nitric oxide

Nitric oxide modulates HIV-1 replication

Hepatic gamma-cystathionase deficiency in patients with AIDS

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression

Sepsis and immunosenescence in the elderly patient: A review

Dysregulation of adult T-cell leukemia-derived factor (ADF)/ thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients

The immune response during acute HIV-1 infection: Clues for vaccine development

Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences

Recognition of microorganisms and activation of the immune response

Early life socioeconomic position and immune response to persistent infections among elderly Latinos

Virus interactions with endocytic pathways in macrophages and dendritic cells

Signals required for programming effector and memory development by CD8+ T cells

Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives

The doctrine of original antigenic sin: Separating good from evil

Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G

Pattern recognitions receptors in immunodeficiency disorders

SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells

Resistance of major histocompatibility complex class B (MHC-B) to Nef-mediated downregulation relative to that of MHC-A Is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals

Neuropathogenesis of Japanese encephalitis in a primate model

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

Apoptosis by death factor

Elevation of plasma thioredoxin levels in HIV-infected individuals

Interleukin-6 rescues lymphocyte from apoptosis and exhaustion induced by chronic hepatitis C virus infection

Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection

Maternal nutritional status during pregnancy and infant immune response to routine childhood vaccinations

Systems biology and immune aging

Evidências do impacto da suplementação de vitamina A no grupo materno-infantil. Cadernos de Saúde Pública

Immunology of breast milk

Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection

Immune evasion via SARS-CoV-2 ORF8 protein?

Immune response to HIV

Reactive oxygen species and nitric oxide in viral diseases

Living in oblivion: HIV immune evasion

Human milk oligosaccharides and immune system development

Hepatitis C virus and human cytomegalovirus-natural killer cell subsets in persistent viral infections

Immune regulation and evasion of mammalian host cell immunity during viral infection

Unraveling peroxynitrite formation in biological systems

Plasmacytoid dendritic cells: Recent progress and open questions

Manipulating the mediator: Modulation of the alternative complement pathway C3 convertase in health, disease and therapy

Understanding the human T cell response to dengue virus

MDA5 and LGP2: accomplices and antagonists of antiviral signal transduction

Triggering receptor expressed on myeloid cells-1 (TREM-1): A new player in antiviral immunity?

HLA-E peptide repertoire and dimorphism-centerpieces in the adaptive NK cell puzzle?

Hepatitis C virus-induced monocyte differentiation into polarized M2 macrophages promotes stellate cell activation via TGF-β. Cellular and Molecular Gastroenterology and Hepatology

The APOBEC protein family: United by structure, divergent in function

CCR5 plays important roles in hepatitis B infection

A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells

Antiviral effect of nitric oxide during Japanese encephalitis virus infection

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

Efeitos da suplementação com zinco sobre o crescimento, sistema imunológico e diabetes

Genome sequence of a human tumorigenic poxvirus: Prediction of specific host response-evasion genes

MDA7/IL-24 is an anti-viral factor that inhibits influenza virus replication

Antiviral innate immunity pathways

HLA-E: exploiting pathogen-host interactions for vaccine development

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

Cooperation between different variants: A unique potential for virus evolution

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

Plasmacytoid dendritic cells respond directly to apoptotic cells by secreting immune regulatory IL-10 or IFN-α

Egr2 and 3 inhibit T-bet-mediated IFN-γ production in T cells

Functions and regulation of the APOBEC family of proteins

Virokines: novel immunomodulatory agents

The chemokine receptor CCR5 in the central nervous system

Epstein-Barr virus entry into cells

The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G

Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals

Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques

HIV-1 infection modulates IL-24 expression which contributes to cell apoptosis in vitro

Antiviral memory phenotype T cells in unexposed adults

Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient

40 years of the human T-cell leukemia virus: Past, present, and future. F1000Research, 8, F1000

CG dinucleotide suppression enables antiviral defence targeting non-self RNA

A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro

Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication

Within-patient mutation frequencies reveal fitness costs of CpG dinucleotides and drastic amino acid changes in HIV

Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms

The role of nitric oxide in metabolic regulation of Dendritic cell immune function

The origin of the recent swine influenza A(H1N1) virus infecting humans

VSV replication in neurons is inhibited by type I IFN at multiple stages of infection

CpG-recoding in Zika virus genome causes host-age-dependent attenuation of infection with protection against lethal heterologous challenge in mice

Mechanisms of hepatitis B virus persistence

RNA virus attenuation by codon pair deoptimisation is an artefact of increases in CpG/UpA dinucleotide frequencies. eLife, 3, e04531

Malnutrition prevalence remains alarming: stunting is declining too slowly while wasting still impacts the lives of far too many young children

Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C

Identification of nitrated immunoglobulin variable regions in the HIV-infected human brain: Implications in HIV infection and immune response

Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis

Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections

Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect

HCV Pit stop at the lipid droplet: Refuel lipids and put on a lipoprotein coat before exit. Cells

Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye

Cord blood vitamin D status impacts innate immune responses

The CpG dinucleotide content of the HIV-1 envelope gene may predict disease progression

Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis

HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state

Viruses use stealth technology to escape from the host immune system

Molecular mechanisms of HIV entry

Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells

Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation

Genetic ancestry and population differences in levels of inflammatory cytokines in women: Role for evolutionary selection and environmental factors

Relationship of SARS-CoV to other pathogenic RNA viruses explored by tetranucleotide usage profiling

High glucose induces reactivation of latent Kaposi's sarcomaassociated herpesvirus

T cell immunity to enterovirus 71 infection in humans and implications for vaccine development

Structural mechanism of RNA recognition by the RIG-I-like receptors

Interferon regulatory factor 3 in adaptive immune responses

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

CD8+ T cells: Foot soldiers of the immune system

The ORF8 protein of SARS-CoV-2 mediates immune evasion through potently downregulating MHC-I. bioRxiv, 111823

Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation

Deep sequencing of the HIV-1 ENV gene reveals discrete X4 lineages and linkage disequilibrium between X4 and R5 viruses in the V1/V2 and V3 variable regions

Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency

Factors that influence the immune response to vaccination

Ribose 2'-Omethylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5

Host-virus interaction and viral evasion